Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches
- Nishant Patel
- , Jason Woo
- , Michael A. Liss
- , Kerrin L. Palazzi
- , J. Michael Randall
- , Reza Mehrazin
- , Ramzi Jabaji
- , Hossein S. Mirheydar
- , Kyle Gillis
- , Hak J. Lee
- , Anthony L. Patterson
- , Christopher J. Kane
- , Frederick Millard
- , Ithaar H. Derweesh
Producción científica: Article › revisión exhaustiva
12
El enlace se abre en una pestaña nueva
Citas
(Scopus)